The Spanish Society of Hematology and Hemotherapy (SEHH) has reported that Spain relies heavily on international sources for plasma, with only 25 percent of the country's immunoglobulin supply derived from domestic donors. The remaining 75 percent is imported, primarily from the United States. This data, based on 2025 figures, highlights a significant gap between domestic collection and clinical requirements.
Health authorities have characterized this reliance as a concern, particularly as the national demand for plasma products continues to grow by more than 8 percent annually. To achieve self-sufficiency and reduce dependence on foreign imports, experts indicate that Spain would need to increase its current rate of plasma donations sevenfold.
In-depth summary · AI, neutral